Stock TBIO TELESIS BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Telesis Bio, Inc.

Equities

TBIO

US1920031010

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.3184 USD -0.93% Intraday chart for Telesis Bio, Inc. +3.04% -20.20%
Apr. 18 Telesis Bio, Inc. Announces Appointment of Eric Esser to the Board of Directors CI
Apr. 18 Telesis Bio Inc. Announces Strategic Focus on Game-Changing Gibson Sola Enzymatic DNA Synthesis Platform and BioXp mRNA Solutions CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
KeyBanc Downgrades Telesis Bio to Sector Weight From Overweight, Cites 'Limited Top-Line Visibility' Amid 'Tepid Biopharma Spending Environment'
MT
KeyBanc Capital Markets Adjusts Price Target on Codex DNA to $5 From $8, Maintains Overweight Rating
MT
KeyBanc Adjusts Codex DNA's Price Target to $8 From $30, Keeps Overweight Rating
MT
CODEX DNA : Cowen Starts Codex DNA at Outperform
MT
CODEX DNA : Jefferies Starts Codex DNA at Buy With $23 Price Target
MT
CODEX DNA : KeyBanc Starts Codex DNA at Overweight With $30 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TBIO Stock
  4. News Telesis Bio, Inc.
  5. Analyst Reco.